SPL 3.09% 9.4¢ starpharma holdings limited

The under 45 cohort didn’t fail. They reached the endpoint...

  1. bid
    646 Posts.
    lightbulb Created with Sketch. 164
    The under 45 cohort didn’t fail. They reached the endpoint early! so at day 6 there was no statistical significance to report against placebo. Graphs would show that curves. Why they were not included in the announcement was a mistake. Scientists understand, your average retail shareholder does not. I did not till recently. DYOR.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.